FLOW - ETF AI Analysis
Top Page
Global X U.S. Cash Flow Kings 100 ETF (FLOW)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Archer Daniels Midland, Altria, and DR Horton, have shown strong year-to-date gains, helping support the fund’s overall results.
Broad Sector Diversification
The ETF spreads its investments across many sectors, including consumer cyclical, technology, health care, energy, and others, which helps reduce reliance on any single industry.
Moderate Expense Ratio
The fund’s expense ratio is relatively moderate for an actively targeted strategy, so fees are not excessively eating into potential returns.
Negative Factors
Recent Weak Short-Term Performance
The ETF has shown weak returns over the past month and slightly negative performance year-to-date, which may concern investors looking for near-term strength.
Heavy U.S. Concentration
With almost all assets invested in U.S. companies and only a small slice in Canada, the fund offers limited geographic diversification and is highly tied to the U.S. market.
Some Lagging Top Holdings
A few key positions, such as Fox and Diamondback, have posted weak year-to-date results, which can drag on the fund’s overall performance.
FLOW vs. SPDR S&P 500 ETF (SPY)
AUM25.95M
RegionNorth America
Expense Ratio0.25%
Beta0.79
IssuerGlobal X
Inception DateJul 10, 2023
Dividend Yield2.23%
Asset ClassEquity
Index TrackedGlobal X U.S. Cash Flow Kings 100 Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,223
30 Day Avg. Volume4,184
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
41.78Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering99
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FLOW Summary
The Global X U.S. Cash Flow Kings 100 ETF (FLOW) tracks the Global X U.S. Cash Flow Kings 100 Index, focusing on 100 U.S. companies that generate strong, steady cash flow. It holds a mix of businesses across many sectors, including consumer, technology, energy, and health care. Well-known names include Ford Motor and Accenture. Someone might invest in FLOW to get broad exposure to financially solid companies that may be better able to handle economic ups and downs. A key risk is that the ETF still moves with the stock market, so its value can go up and down over time.
How much will it cost me?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as it focuses on a specific strategy targeting companies with strong cash flow metrics while keeping costs relatively affordable.
What would affect this ETF?The Global X U.S. Cash Flow Kings 100 ETF (FLOW) could benefit from strong economic growth in the U.S., particularly in sectors like technology and consumer cyclical, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact cash flow generation for companies in these sectors, while regulatory changes in industries like healthcare or energy might also pose risks. The ETF’s focus on financially resilient companies may help mitigate some of these challenges over time.
FLOW Top 10 Holdings
FLOW is leaning hard into U.S. energy and cash-rich cyclicals, and that’s where most of the action is. Devon Energy, APA, Diamondback, and Ovintiv have been rising, effectively powering the fund like a cluster of high-octane engines at the front of the portfolio. CF Industries is another bright spot, adding a strong materials kicker. On the flip side, steadier names like Archer Daniels Midland and Altria, along with health care holdings such as Bristol-Myers and Biogen, have been more mixed to lagging, acting as ballast rather than boosters in this all-U.S. lineup.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| APA | 3.10% | $805.88K | $15.20B | 187.57% | 73 Outperform | |
| Devon Energy | 2.98% | $774.20K | $30.78B | 73.54% | 79 Outperform | |
| Diamondback | 2.84% | $736.98K | $54.65B | 56.00% | 81 Outperform | |
| Cf Industries Holdings | 2.65% | $687.85K | $20.12B | 81.82% | 72 Outperform | |
| Archer Daniels Midland | 2.55% | $662.04K | $35.31B | 71.78% | 64 Neutral | |
| Altria Group | 2.32% | $601.48K | $111.26B | 18.14% | 64 Neutral | |
| Bristol-Myers Squibb | 2.28% | $592.87K | $120.82B | 7.99% | 78 Outperform | |
| Biogen | 2.24% | $582.54K | $25.29B | 48.79% | 74 Outperform | |
| Ovintiv | 2.22% | $576.46K | $16.84B | 80.92% | 60 Neutral | |
| Cardinal Health | 2.13% | $553.31K | $50.03B | 69.18% | 66 Neutral |
FLOW Technical Analysis
Positive
―
Price Trends
35.98
Negative
35.77
Positive
34.42
Positive
Market Momentum
-0.09
Negative
54.79
Neutral
78.60
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FLOW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.34, equal to the 50-day MA of 35.98, and equal to the 200-day MA of 34.42, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 54.79 is Neutral, neither overbought nor oversold. The STOCH value of 78.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FLOW.
FLOW Peer Comparison
Comparison Results
Performance Comparison
FLOW
Global X U.S. Cash Flow Kings 100 ETF
35.90
10.21
39.74%
YALL
God Bless America ETF
―
―
―
BAMD
Brookstone Dividend Stock ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
BUZZ
VanEck Social Sentiment ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents